DiscoverLeaders in Healthcare68. The Future of Medically Supervised Weight Loss | Dr. Jonathan Kaplan
68. The Future of Medically Supervised Weight Loss | Dr. Jonathan Kaplan

68. The Future of Medically Supervised Weight Loss | Dr. Jonathan Kaplan

Update: 2025-02-06
Share

Description

This week we discuss the integration of medications and GLP-1s (like Ozempic) into weight management.



Dr Kaplan explains the ethical considerations of prescribing weight loss medications, the additional unexpected benefits of these medications for patients, the role of compounding pharmacies, and the evolution of virtual care in healthcare. Dr. Kaplan emphasizes the importance of patient experience, medication tolerability, and the future of weight loss treatments, including innovative medications on the horizon.



Dr. Jonathan Kaplan is a board-certified plastic surgeon and founder of Dr. Well by BuildMyHealth. Hosted by Dr. Jordan Vollrath, a family physician and mental health counsellor.



Links:
Cherry Health: ⁠https://www.cherry.health/⁠
Dr Well: ⁠https://www.drwell.com//




00:00
Introduction to Dr. Jonathan Kaplan
06:38
Ethics of Prescribing Weight Loss Medications
13:23
Cost Considerations and Financial Implications
20:23
Future of Weight Loss Medications
26:05
Personal Fitness Routines and Lifestyle Choices
31:44
The Evolution of Healthcare Pricing Transparency
37:10
Navigating Virtual Care Critiques
41:41
Understanding Compounding Pharmacies
47:56
The Future of Medication Access

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

68. The Future of Medically Supervised Weight Loss | Dr. Jonathan Kaplan

68. The Future of Medically Supervised Weight Loss | Dr. Jonathan Kaplan

Cherry Health